The Ras-related C3 botulinum toxin substrate 1 (RAC1), a small signaling GTPase, has been found to be indirectly regulated by CBX3 during tumor progression [18], and its gene has been recently found to be amplified in cancer [19, 20]. Here, RAC1 is linked to cancer.